Correlation of growth fraction by Ki-67 immunohistochemistry with histologic factors and hormone receptors in operable breast carcinoma.

Breast Cancer Research and Treatment
G GaspariniP Bevilacqua

Abstract

Breast cancer tissue samples obtained from 147 Stage I and II patients were tested with the monoclonal antibody Ki-67 and avidin-biotin-peroxidase complex in frozen sections. The percentage of cells with nuclear staining ranged from 5% to 65%. The frequency of Ki-67 positivity was classified in five groups: 0% (45/147 = 31%); 5-9% (38/147 = 26%); 10-19% (15/147 = 10%); 20-39% (24/147 = 16%) and greater than or equal to 40% (25/147 = 17%). The mean value was 20%, median 18% with standard deviation of 14.5%. A significant positive correlation was observed between the presence of high Ki-67 nuclear staining rate with pathological tumor size (p = 0.003), histologic grading (p = 0.04), and axillary lymph node metastases (p = 0.009). An inverse significant correlation was found between Ki-67 and estrogen receptor expression (p less than 0.001). No correlation was observed with progesterone receptor expression or menopausal status. The overall picture is of an inverse relationship between high growth fraction determined with Ki-67 antibody and tumor differentiation parameters. These correlations confirm those already reported by thymidine labeling index and flow cytometry methods. The proliferative rate determined with Ki-67 antibody ...Continue Reading

References

Jan 1, 1985·Breast Cancer Research and Treatment·W l McGuireT E Kute
Sep 1, 1986·Journal of Clinical Pathology·J GerdesH Stein
Sep 1, 1986·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J LundyM V Viola
Oct 1, 1987·Breast Cancer Research and Treatment·W L McGuire
Jan 1, 1986·Breast Cancer Research and Treatment·R SilvestriniG Bonadonna
Feb 1, 1986·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D L Dexter, J T Leith
Oct 15, 1985·Cancer·R SilvestriniG Gasparini
Dec 27, 1985·JAMA : the Journal of the American Medical Association
May 1, 1973·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
Jan 15, 1983·International Journal of Cancer. Journal International Du Cancer·J GerdesH Stein
Dec 1, 1983·The New England Journal of Medicine·G M ClarkJ S Marshall
Apr 15, 1984·International Journal of Cancer. Journal International Du Cancer·M TubianaE P Malaise

❮ Previous
Next ❯

Citations

Aug 22, 1997·International Journal of Cancer. Journal International Du Cancer·A MolinoG L Cetto
Jan 1, 1996·Breast Cancer Research and Treatment·A BonettiG L Cetto
Dec 17, 2009·Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging·Julia TchouMitchell Schnall
Aug 1, 1996·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·V Kuenen-BoumeesterS C Henzen-Logmans
May 1, 1997·Breast Cancer Research and Treatment·A MakrisC K Osborne
Mar 1, 1993·The American Journal of the Medical Sciences·J A FigueroaW L McGuire
Dec 7, 2005·International Journal of Cancer. Journal International Du Cancer·Christian RuizGuido Sauter
Jan 1, 1992·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M F PichonE Milgrom
May 9, 2006·Pathology, Research and Practice·Piotr PotemskiRadzislaw Kordek
Feb 28, 2003·Applied Immunohistochemistry & Molecular Morphology : AIMM·Annamaria MolinoGian Luigi Cetto
Jan 1, 1997·Plant Foods for Human Nutrition·Z ZdunczykR Amarowicz

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.